Development of pH-adjusted NMR methodology for quantitation of caffeoylquinic acid derivatives and evaluation of their antimalignant pleural mesothelioma potential

April 25, 2025 | Comments Off on Development of pH-adjusted NMR methodology for quantitation of caffeoylquinic acid derivatives and evaluation of their antimalignant pleural mesothelioma potential

Journal of Pharmaceutical and Biomedical Analysis 2025 July 15 [Link] Hau Thi Hong Bui, Yoon-Jin Lee, Trung Huy Ngo, Punam Thapa, Yun-Seo Kil, Chang Yeol Lee, Hyukjae Choi, Kyu Joon…

Current and Future Perspective of PET/CT in Response Assessment of Malignant Pleural Mesothelioma

April 24, 2025 | Comments Off on Current and Future Perspective of PET/CT in Response Assessment of Malignant Pleural Mesothelioma

Seminars in Nuclear Medicine 2025 March [Link] Manar Badarna, Zohar Keidar, Elite Arnon-Sheleg Abstract Malignant pleural mesothelioma (MPM) is a rare but aggressive cancer characterized by its unique growth patterns,…

FABP5 is a key player in metabolic modulation and NF-κB dependent inflammation driving pleural mesothelioma

April 23, 2025 | Comments Off on FABP5 is a key player in metabolic modulation and NF-κB dependent inflammation driving pleural mesothelioma

Communications Biology 2025 February 27 [Link] Eleonora Vecchio, Raffaella Gallo, Selena Mimmi, Debora Gentile, Caterina Giordano, Emilio Straface, Rossana Marino, Carmen Caiazza, Arianna Pastore, Maria Rosaria Ruocco, Alessandro Arcucci, Marco…

Leveraging Immunogenic Cell Death to Enhance the Immune Response against Malignant Pleural Mesothelioma Tumors

April 22, 2025 | Comments Off on Leveraging Immunogenic Cell Death to Enhance the Immune Response against Malignant Pleural Mesothelioma Tumors

Journal of the American Chemical Society 2025 March 5 [Link] Meng Rui Chang, Egor M Matnurov, Chengnan Wu, Jemma Arakelyan, Ho-Jung Choe, Vladimir Kushnarev, Jian Yu Yap, Xiu Xuan Soo,…

Telomeres and telomerase in mesothelioma: Pathophysiology, biomarkers and emerging therapeutic strategies (Review)

April 21, 2025 | Comments Off on Telomeres and telomerase in mesothelioma: Pathophysiology, biomarkers and emerging therapeutic strategies (Review)

International Journal of Oncology 2025 March [Link] Dimitrios Andreikos, Demetrios A Spandidos, Vasiliki Epameinondas Georgakopoulou Abstract Malignant mesothelioma (MM) is a rare but aggressive cancer linked to asbestos exposure and…

miRNA-503 inhibition exerts anticancer effects and reduces tumor growth in mesothelioma

April 18, 2025 | Comments Off on miRNA-503 inhibition exerts anticancer effects and reduces tumor growth in mesothelioma

Journal of Experimental & Clinical Cancer Research 2025 February 22 [Link] Miriam Piccioni, Francesco Di Meo, Anna Valentino, Virginia Campani, Maddalena Arigoni, Mirella Tanori, Mariateresa Mancuso, Rossana Cuciniello, Marco Tomasetti,…

The phenogenomic landscapes of pleural mesothelioma tumor microenvironment predict clinical outcomes

April 17, 2025 | Comments Off on The phenogenomic landscapes of pleural mesothelioma tumor microenvironment predict clinical outcomes

Journal of Translational Medicine 2025 February 20 [Link] Federica Torricelli, Filomena Spada, Cynthia Bishop, Katrina Todd, Daisuke Nonaka, Nedyalko Petrov, Manuela Terranova Barberio, Alan G Ramsay, Richard Ellis, Alessia Ciarrocchi,…

CD276 as a critical independent biomarker and immune checkpoint inhibitor target in epithelioid mesothelioma-TCGA study

April 16, 2025 | Comments Off on CD276 as a critical independent biomarker and immune checkpoint inhibitor target in epithelioid mesothelioma-TCGA study

Journal of Thoracic Disease 2025 January 24 [Link] Yuko Aoki, Ken Arimura, Kenzo Hiroshima, Yasuto Sato, Mitsuko Kondo, Etsuko Tagaya Abstract Background: CD276 is an immune checkpoint, and immune checkpoint…

DNA methylation status classifies pleural mesothelioma cells according to their immune profile: implication for precision epigenetic therapy

April 15, 2025 | Comments Off on DNA methylation status classifies pleural mesothelioma cells according to their immune profile: implication for precision epigenetic therapy

Journal of Experimental & Clinical Cancer Research 2025 February 18 [Link] Maria Fortunata Lofiego, Rossella Tufano, Emma Bello, Laura Solmonese, Francesco Marzani, Francesca Piazzini, Fabrizio Celesti, Francesca Pia Caruso, Teresa…

Potential utility of miRNAs derived from pleural fluid extracellular vesicles to differentiate between benign and malignant pleural effusions

April 14, 2025 | Comments Off on Potential utility of miRNAs derived from pleural fluid extracellular vesicles to differentiate between benign and malignant pleural effusions

Translational Lung Cancer Research 2025 January 24 [Link] Tian Mun Chee, Caeli J Zahra, Kwun M Fong, Ian A Yang, Rayleen V Bowman Abstract Background: Cytological examination is of suboptimal…

Categories